Table 3 Clinical outcome and task performance
|  | MPH (n = 16) | ATX (n = 14) | p value | ||||
|---|---|---|---|---|---|---|---|
Pre- | Post- | Pre- | Post- | MPH | ATX | Â | |
Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | Pre vs posta | Pre vs posta | Time × Drug Interactionb | |
ARF | 30.63 (10.65) | 17.06 (10.51) | 32.29 (13.46) | 22.71 (10.54) | 0.000 | 0.001 | 0.208 |
ARI | 16.75 (5.52) | 10.13 (6.01) | 18.29 (6.84) | 13.71 (6.27) | 0.000 | 0.010 | 0.272 |
ARH | 13.88 (6.72) | 6.94 (5.47) | 14.00 (7.99) | 9.00 (4.84) | 0.000 | 0.002 | 0.295 |
SCWC-1 | 18.31 (7.66) | 27.75 (11.70) | 25.86 (8.76) | 33.79 (13.57) | 0.000 | 0.000 | 0.520 |
SCWC-2 | 19.81 (9.56) | 28.13 (10.54) | 29.36 (11.11) | 33.50 (12.82) | 0.000 | 0.033 | 0.098 |
SCWC-3 | 21.19 (9.17) | 26.44 (10.91) | 25.36 (10.35) | 34.07 (12.16) | 0.006 | 0.002 | 0.210 |